Le Lézard
Classified in: Ebola virus, Health
Subject: SVY

Global Mixed Mode Chromatography Resin Market to 2025 - Market Size is Expected to Reach USD 130.3 Million


DUBLIN, Nov. 13, 2018 /PRNewswire/ --

The "Mixed Mode Chromatography Resin Market Analysis Report By Technique (Ion exchange - Hydrophobic, Hydroxyapatite), By End Use (Pharmaceutical & Biotechnology), And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The global mixed mode chromatography resin market size is expected to reach USD 130.3 million by 2025, exhibiting a 7.1% CAGR during the forecast period.

Growing number of contract manufacturing organizations (CMOs) and contract research organizations (CROs), along with increasing use of chromatography resin in separation of monoclonal antibodies, is anticipated to propel the market.

The Ion exchange - Hydrophobic resin segment is expected to dominate the global market till 2025. Demand for this technique is attributed to growth in drug discovery by pharmaceutical companies. These companies use chromatography techniques to separate complex mixtures and purification of materials. Increasing number of epidemic diseases such as Zika and Ebola is expected to further boost the mixed mode chromatography resin market.

Asia Pacific, especially China and India, is expected to generate significant demand for mixed mode chromatography resin owing to growing pharmaceutical sector, coupled with abundance of high skilled workforce and increase in disposable income.

Presence of global pharmaceutical and biotechnology companies, along with their research and development facilities, has enabled North America to be a key market for mixed mode chromatography resin. Massive healthcare expenditure is also driving the expansion of the market in this region.

Further key findings from the report suggest

Key Topics Covered:

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 Market Variables, Trends, and Scope
3.1 Market segmentation
3.2 Penetration & growth prospect mapping, 2014 - 2025
3.3 Value chain analysis
3.4 Regulatory framework
3.5 Technology overview
3.6 Market dynamics
3.6.1 Market driver analysis
3.6.1.1 High demand considering advances in drug development
3.6.2 Market restraint analysis
3.6.2.1 Costlier than other separation techniques
3.7 Industry analysis - Porter's
3.8 PESTEL analysis

Chapter 4 Mixed Mode Chromatography Resin Market: Technique Estimates & Trend Analysis
4.1 Technique movement analysis, 2017 & 2025
4.2 Global Mixed Mode Chromatography Resin demand by technique, 2014 - 2025 (Thousand litres)
4.2.1 Mixed Mode Chromatography Resin market estimates & forecast, 2014 - 2025
4.3 Ion exchange - Hydrophobic
4.4 Hydroxyapatite

Chapter 5 Mixed Mode Chromatography Resin Market: End Use Estimates & Trend Analysis
5.1 End use movement analysis, 2017 & 2025
5.2 Global Mixed Mode Chromatography Resin demand, by end use, 2014 - 2025 (Thousand litres) (USD Million)

Chapter 6 Mixed Mode Chromatography Resin Market: Regional Estimates & Trend Analysis
6.1 Regional Market Introduction, 2017 & 2025
6.2 Global Mixed Mode Chromatography Resin demand, by region, 2014 - 2025 (Thousand litres) (USD Million)
6.2.1 Mixed Mode Chromatography Resin market estimates & forecast, 2014 - 2025

Chapter 7 Competitive Landscape
7.1 Vendor landscape
7.2 Competitive environment
7.3 Strategy framework

Chapter 8 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/t2slx8/global_mixed_mode?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 20:31
Fitness International, LLC opened a new Club Studio location in Kingwood, Texas. The new 40,000 square foot club features five innovative boutique fitness studios that were carefully curated to create a unique experience, along with recovery services...

at 19:35
Mirum Pharmaceuticals, Inc. today announced that on May 10, 2024, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 38,600 shares of common stock and 19,300...

at 19:00
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759...

at 18:36
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that in connection with the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary Inhibrx Biosciences, Inc. ("SpinCo") to holders of shares of...

at 17:55
Asia Green Biotechnology Corp. ("Asia Green" or the "Company") announces that, further to its news releases dated April 17, 2024, April 26, 2024, and May 8, 2024, the Management Cease Trade Order ("MCTO") issued by the...

at 17:53
The following statement is being issued by Rice Harbut Elliott LLP regarding the Ruckman v. Biotrade Canada Ltd. et al. lawsuit: All persons in Canada who purchased or ingested U-Dream on or after August 18, 2014 (the "Class" or "Class Members")...



News published on and distributed by: